2 Information about nintedanib

Marketing authorisation indication

2.1 Nintedanib (Ofev, Boehringer Ingelheim) is indicated 'for the treatment of idiopathic pulmonary fibrosis'.

Dosage in the marketing authorisation

2.2 The dosage schedule is available in the summary of product characteristics for nintedanib.


2.3 The price of nintedanib is £2,151.10 per pack of 60 capsules, each containing 150 mg (excluding VAT; BNF online accessed October 2022).

2.4 The company has a commercial arrangement. This makes nintedanib available to the NHS with a discount. The size of the discount is commercial in confidence. It is the company's responsibility to let relevant NHS organisations know details of the discount.